Targeting the Human Macrophage with Combinations of Drugs and Inhibitors of Ca2+ and K+ Transport to Enhance the Killing of Intracellular Multi-Drug Resistant Mycobacterium tuberculosis (MDR-TB) - a Novel, Patentable Approach to Limit the Emergence of XDR-TB

By  

Recent Patents on Anti-Infective Drug Discovery, Vol. 6, Iss. 2, 2011-05 ,pp. : 110-117

Bentham Science Publishers

Access to resources Recommend Favorite

Current Approaches for New TB Drugs

By  

Current Respiratory Medicine Reviews, Vol. 10, Iss. 2, 2014-06 ,pp. : 88-96

Bentham Science Publishers

Access to resources Recommend Favorite

Current Approaches for New TB Drugs

By  

Current Respiratory Medicine Reviews, Vol. 10, Iss. 2, 2014-11 ,pp. : 88-96

Bentham Science Publishers

Access to resources Recommend Favorite

Improving existing tools for Mycobacterium xenopi treatment: assessment of drug combinations and characterization of mouse models of infection and chemotherapy

By Andréjak Claire   Almeida Deepak V.   Tyagi Sandeep   Converse Paul J.   Ammerman Nicole C.   Grosset Jacques H.  

Journal of Antimicrobial Chemotherapy, Vol. 68, Iss. 3, 2013-03 ,pp. : 659-665

Oxford University Press

Access to resources Recommend Favorite

Preclinical Testing of Drug-Induced Proarrhythmia: Value of Transgenic Models

By  

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 5, Iss. 4, 2007-10 ,pp. : 289-294

Bentham Science Publishers

Access to resources Recommend Favorite